Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)

National Institutes of Health

Closes Jun 10, 2027

Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed)

National Institutes of Health

Drug Development Infrastructure Supporting the Research Community in Medication Repurposing for Substance Use Disorders

National Institutes of Health

Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)

National Institutes of Health

Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)

National Institutes of Health

Closes Feb 18, 2027